vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ALLIANCE ENTERTAINMENT HOLDING CORP (AENT). Click either name above to swap in a different company.
ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $268.1M, roughly 1.4× ACADIA PHARMACEUTICALS INC). ALLIANCE ENTERTAINMENT HOLDING CORP runs the higher net margin — 2.5% vs 1.4%, a 1.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -6.3%). Over the past eight quarters, ALLIANCE ENTERTAINMENT HOLDING CORP's revenue compounded faster (32.1% CAGR vs 5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.
ACAD vs AENT — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $268.1M | $368.7M |
| Net Profit | $3.6M | $9.4M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 4.7% |
| Net Margin | 1.4% | 2.5% |
| Revenue YoY | 9.7% | -6.3% |
| Net Profit YoY | — | 32.8% |
| EPS (diluted) | $0.02 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | — | ||
| Q4 25 | $284.0M | $368.7M | ||
| Q3 25 | $278.6M | $254.0M | ||
| Q2 25 | $264.6M | $227.8M | ||
| Q1 25 | $244.3M | $213.0M | ||
| Q4 24 | $259.6M | $393.7M | ||
| Q3 24 | $250.4M | $229.0M | ||
| Q2 24 | $242.0M | $236.9M |
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | $9.4M | ||
| Q3 25 | $71.8M | $4.9M | ||
| Q2 25 | $26.7M | $5.8M | ||
| Q1 25 | $19.0M | $1.9M | ||
| Q4 24 | $143.7M | $7.1M | ||
| Q3 24 | $32.8M | $397.0K | ||
| Q2 24 | $33.4M | $2.5M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 4.7% | ||
| Q3 25 | 12.8% | 4.2% | ||
| Q2 25 | 12.2% | 4.3% | ||
| Q1 25 | 7.9% | 1.7% | ||
| Q4 24 | 59.1% | 3.8% | ||
| Q3 24 | 12.6% | 0.9% | ||
| Q2 24 | 12.6% | 0.2% |
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | 2.5% | ||
| Q3 25 | 25.8% | 1.9% | ||
| Q2 25 | 10.1% | 2.5% | ||
| Q1 25 | 7.8% | 0.9% | ||
| Q4 24 | 55.4% | 1.8% | ||
| Q3 24 | 13.1% | 0.2% | ||
| Q2 24 | 13.8% | 1.1% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $0.18 | ||
| Q3 25 | $0.42 | $0.10 | ||
| Q2 25 | $0.16 | $0.11 | ||
| Q1 25 | $0.11 | $0.04 | ||
| Q4 24 | $0.86 | $0.14 | ||
| Q3 24 | $0.20 | $0.01 | ||
| Q2 24 | $0.20 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $117.6M |
| Total Assets | $1.6B | $434.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | $4.3M | ||
| Q2 24 | $177.1M | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $117.6M | ||
| Q3 25 | $917.3M | $108.1M | ||
| Q2 25 | $822.4M | $103.2M | ||
| Q1 25 | $765.2M | $97.4M | ||
| Q4 24 | $732.8M | $95.6M | ||
| Q3 24 | $577.2M | $88.0M | ||
| Q2 24 | $516.7M | $87.6M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $434.1M | ||
| Q3 25 | $1.3B | $383.0M | ||
| Q2 25 | $1.2B | $361.2M | ||
| Q1 25 | $1.1B | $349.4M | ||
| Q4 24 | $1.2B | $401.7M | ||
| Q3 24 | $976.9M | $395.7M | ||
| Q2 24 | $914.1M | $340.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $-16.5M |
| Free Cash FlowOCF − Capex | — | $-16.9M |
| FCF MarginFCF / Revenue | — | -4.6% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | -1.76× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $-16.5M | ||
| Q3 25 | $74.3M | $2.7M | ||
| Q2 25 | $64.0M | $10.7M | ||
| Q1 25 | $20.3M | $2.5M | ||
| Q4 24 | $40.4M | $25.3M | ||
| Q3 24 | $63.2M | $-11.6M | ||
| Q2 24 | $25.0M | $9.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-16.9M | ||
| Q3 25 | $73.9M | $2.4M | ||
| Q2 25 | — | $10.7M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | $-11.6M | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -4.6% | ||
| Q3 25 | 26.5% | 0.9% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -5.1% | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | -1.76× | ||
| Q3 25 | 1.03× | 0.56× | ||
| Q2 25 | 2.40× | 1.86× | ||
| Q1 25 | 1.07× | 1.33× | ||
| Q4 24 | 0.28× | 3.57× | ||
| Q3 24 | 1.93× | -29.31× | ||
| Q2 24 | 0.75× | 3.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.